RESOURCES | Research | Announcement

CRB Monitor 2023 Business License Activity Review
Published on February 28, 2024
The Cannabis Market Retrenches, Reassesses & Redeploys

Despite a few states launching their legal cannabis programs, business licensing in the United States and Canada plateaued in 2023. After six years of growth, companies in larger, more mature states struggled to optimize their operations amid falling product pricing, penalizing tax policies and a Balkanized marketplace thwarting economies of scale.

Read CRB Monitor’s 2023 Business License Activity Review to get the full picture of cannabis business licensing, including applications, approved licenses and active operations.

Among the licensing highlights in our exclusive research report:

  • Total active business licenses in the U.S. declined -4%
  • Approved and pending licenses surged in the beginning of the year, only to retreat -8% in the fourth quarter
  • Pre-licensing activity peaked at 8,896 applications at the beginning of the year, then plummeted by -40% in the second half of 2023
  • Canada’s cannabis licensing landscape remained stable with active business licenses increasing by 2%

This issue also features a roundup of U.S. legislation, regulation and markets in 2023.

  • “Despite a Couple of Big Steps, the Feds Didn’t Travel Far as More States Liberalize”
  • “Rocky Start in Several New Markets in 2023”

And find out which states may become new adult-use markets in “What to watch for in 2024.” 

Register to download your copy today

Subscribe for premium content

Want more of CRB Monitor’s insights into licensing data, cannabis business securities and industry news? Subscribe for our premium content and newsletters. 

Brett Goetschius
Editorial Director, CRB Monitor


Wondering what a Tier 1, Tier 2 or Tier 3 CRB is?

See our seminal ACAMS Today white paper Defining "Marijuana-Related Business" and its update Defining "Cannabis-Related Businesses."

Most Popular

Subscribe For Updates

Explore how CRBMonitor can simplify your cannabis-related compliance challenges.